Zydus Lifesciences Ltd (ZYDUSLIFE)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 1038.50
% Change: 2.82% (Prev Close: 1010.00)

Volume: 12,28,793
% Change: 58.11% (Prev Volume: 7,77,187)

Delivery: 7,19,549
Delivery % : 58.56
% Change: 99.98% (Prev Delivery: 3,59,812)

Turnover: 12,639 Lacs
% Change: 60.15% (Prev Turnover: 7,892)

πŸ’Ή EOD Valuation

P/E Ratio: 22.85
P/B Ratio: 4.36
Market Cap: 104494 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: ZYDUSLIFE
Market Cap: 98717 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 1135.95
52 Week Low: 795.00

All-Time High: 1324.30 Rs.
All-Time Low: 25.51 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
4.99% | 5.00% | 11.92% | -10.61% | 39.52%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 74.99%

Change (3Y | 1Y): 0.11% | 0.01%

Pledged %: 0.00%

FII Holding

FII Holding: 7.13%

Change (3Y | 1Y): 4.27% | -0.18%

DII Holding

DII Holding: 11.09%

Change (3Y | 1Y): -0.85% | 0.14%

Public Holding: 6.74%

🏦 Financial Strength

Debt to Equity: 0.13
Debt: 3213.20 Rs. Cr.

Book Value: 238.05 Rs.
Current Ratio: 1.35
Interest Coverage: 29.70
Free Cash Flow: 5115.50 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 14.52%

Sales Growth Qtr (YOY | QoQ):
5.90% | 0.70%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
10.27% | 15.43% | 14.52%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 11.71%

Profit Growth Qtr (YOY | QoQ):
3.30% | 22.30%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
25.92% | 1.89% | 11.71%

EPS Rs.

EPS (TTM): 45.44 Rs.

EPS Qtr (Last Year | Latest):
14.11 Rs. | 14.58 Rs.

EPS Annual (Last Annual | Annual March):
38.36 Rs. | 44.97 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
26.36% | 2.48%

Net Profit Rs. Cr.

Net Profit (TTM): 4711.10 Rs. Cr.

Net Profit (Annual - March): 4672.60 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
1482.50| 1243.70 | 1521.00

EBITDA Rs. Cr.

EBITDA (Quarter): 2243.40 Rs. Cr.
EBITDA (Previous Yr Ql): 2147.20 Rs. Cr.

EBITDA (Annual - March): 7293.50 Rs. Cr.
EBITDA (Previous Annual): 5655.00 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
20.16% | 26.92%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 29.92%

OPM Qtr (Previous | Current):
32.56% | 31.77%

OPM Annual (5 Yrs | Last Yr | March):
25.73% | 27.54% | 30.37%

Return on Equity %

ROE: 21.21%

ROE (5 Yrs | 3 Yrs | Last Yr):
20.85% | 18.79% | 20.67%

Return on Capital Employed %

ROCE: 24.31%

ROCE (5 Yrs | 3 Yrs | Last Yr):
17.81% | 20.53% | 22.34%

Return on Assets %

ROA (TTM): 14.64%

ROA (5 Yrs | 3 Yrs | Last Yr):
13.31% | 12.91% | 14.61%

PEG Ratio: 11.22
Dividend Yield: 1.12%

PE 3 Yrs: 22.87
PE 5 Yrs: 22.85

Dividend Yield: 1.12%

πŸ‘₯ Company

Zydus Lifesciences Ltd

ZYDUSLIFE

Promoter Holding: %